Christopher Chiu

Also affiliated with Genmab (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting”.

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Blood Advances(2023)10.1182/bloodadvances.2022009517

N/A

0DataRank · unranked

40 citations

Erika M. Gaglione, David Eik, John H. Herrick, J. Le, Inhye E. Ahn +11 more

Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK

Influenza and Other Respiratory Viruses(2024)10.1111/irv.70013

N/A

0DataRank · unranked

2 citations

Rebecca Jane Cox, Othmar G. Engelhardt, Stephanie Ascough, Albert Osterhaus, Guus F. Rimmelzwaan +8 more